Literature DB >> 20216201

Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.

Dmitry V Kazakov1, Luis Requena, Heinz Kutzner, Maria Teresa Fernandez-Figueras, Denisa Kacerovska, Thomas Mentzel, Peter Schwabbauer, Michal Michal.   

Abstract

Syringocystadenocarcinoma papilliferum is an extremely rare cutaneous adnexal neoplasm. The purpose of our investigation was to study a series of syringocystadenocarcinoma papilliferum to document morphologic variations of the neoplasm. This is a light-microscopic study of 6 cases of syringocystadenocarcinoma papilliferum obtained from the combined archival, institutional, and consultations files of the authors over 60 years, complemented by a literature review. Syringocystadenocarcinoma papilliferum invariably occurred in association with syringocystadenoma papilliferum and presented as an in situ adenocarcinoma and/or invasive adenocarcinoma. Additionally, an invasive component was represented by squamous cell carcinoma. Variable present features included pagetoid migration of the neoplastic cells, dirty necrosis, mucinous ductal metaplasia, and ductal changes analogous to those seen in the breast. The ductal changes included patterns identical to columnar cell change (flat epithelial atypia), usual ductal hyperplasia, atypical ductal hyperplasia, and ductal carcinoma in situ. A combination of the above patterns in a single lesion was noted. It is concluded that morphologic diversity of syringocystadenocarcinoma papilliferum is substantial. Its association with the benign counterpart and ductal changes suggests a transformation that may involve usual ductal hyperplasia-atypical ductal hyperplasia-(ductal) adenocarcinoma in situ-invasive adenocarcinoma pathway.

Entities:  

Mesh:

Year:  2010        PMID: 20216201     DOI: 10.1097/DAD.0b013e3181b96c0c

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

1.  Syringocystadenocarcinoma papilliferum at unusual site: inherent lesional histologic polymorphism is the pathognomon.

Authors:  Andleeb Abrari; Urmi Mukherjee
Journal:  BMJ Case Rep       Date:  2011-06-30

2.  A case of giant squamous cell carcinoma of the buttock possibly arose from syringocystadenoma and invaded to the rectum.

Authors:  Megumi Nishioka; Atsushi Tanemura; Takashi Yamanaka; Noriko Umegaki; Mamori Tani; Ichiro Katayama; Ichiro Takemasa; Mitsugu Sekimoto; Koichi Tomita; Noriyuki Tamai
Journal:  J Skin Cancer       Date:  2010-10-18

3.  Syringocystadenocarcinoma Papilliferum in the Perianal Area.

Authors:  Natsuko Iga; Hiroko Fujii; Toshiya Miyake; Mizue Ehara; Satoshi Kore-Eda
Journal:  Case Rep Dermatol       Date:  2015-05-07

4.  Carcino-sarcoma in a case of syringocystadenoma papilliferum: a rare entity.

Authors:  Girish D Bakhshi; Kishor R Wankhede; Mukund B Tayade; Sachin S Shenoy; Sandeep T Gore; Arvind G Valand
Journal:  Clin Pract       Date:  2012-07-12

5.  A new case of syringocystadenocarcinoma papilliferum: a rare pathology for a wide-ranging comprehension.

Authors:  Beatrice Paradiso; Enzo Bianchini; Pierangelo Cifelli; Luigi Cavazzini; Giovanni Lanza
Journal:  Case Rep Med       Date:  2014-05-15

6.  Syringocystadenocarcinoma papilliferum with orbital invasion: a case report with literature review.

Authors:  Carla Pagano Boza; Joaquin Gonzalez-Barlatay; Shoaib Ugradar; Melina Pol; Eduardo Jorge Premoli
Journal:  Ther Adv Ophthalmol       Date:  2019-04-26

7.  [Epidemiological and anatomoclinical features of scalp tumors in black Africans].

Authors:  Assane Diop; Moussa Diallo; Mame Tene Ndiaye; Biram Seck; Saer Diadie; Boubacar Ahy Diatta; Maodo Ndiaye; Zineb Baidouri; Ahmadou Deme; Fatimata Ly; Suzanne Oumou Niang; Assane Kane; Mame Thierno Dieng
Journal:  Pan Afr Med J       Date:  2019-10-17

8.  Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature.

Authors:  Jordan N Halsey; Esteban Fernandez Faith; Suzanna J Logan; Archana Shenoy; Kathleen M Schieffer; Catherine E Cottrell; Anna P Lillis; Jennifer H Aldrink; Bhuvana A Setty; Gregory D Pearson
Journal:  Case Rep Dermatol Med       Date:  2022-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.